baber/WOPTO huggingface dataset:
Patent CA-2706942-A1 (CA)
Inventor: MARQUES PAULO GASPAR JORGE
IPC: B81C1/00
Filed: 2008-11-25
Abstract: A zirconium- and alumina-containing silicate glass suitable for use as a frit with refractory materials such as alumina is disclosed, the silicate glass comprising a glass composition in mole percent (mol %) of: 2< B2O3 < 7 mol % 75 < SiO2 < 80 mol % 3< Al2O3 < 5 mol % 2< ZrO2 < 5 mol % 9< Na2O + K2O < 15 mol % 0< alkali earth + lanthanide < 15 mol % and wherein the total mole percent of SiO2, A1O3 and ZrO2 together is greater than 82 but less than 86, and wherein the total mole percent of B2O3, Na2O, K2O, alkali earths and lanthanides together is greater than 13 and less than 18. Frits (200,600), composites (600) and micro fluidic devices (12) comprising the glass are also disclosed.
Patent CA-2710471-A1 (CA)
Title: Immunoconjugates targeting cd138 and uses thereof
Inventor: KRAUS ELMAR
IPC: C07K16/30
Filed: 2008-12-23
Abstract: Disclosed are immunoconjugates having in particular specificity for CD138 expressed on target cells and which display homogenous targeting. The immunoconjugates may be sterially hindered and/or contain a cleavable linker.
Patent CA-2711885-A1 (CA)
Title: (e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] cyclohepten-5ylidene)-propyl]-phenyl}-methanesulfonamide as glucocorticoid receptor modulator for the treatment of rheumatoid arthritis
Inventor: CARSON MATTHEW WILLIAM
IPC: A61P19/02
Filed: 2009-01-08
Abstract: The present invention provides Compound (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising Compound (I) in combination with one or more pharmaceutically acceptable carriers, excipients, or diluents; and discloses methods for the treatment of inflammatory and immune disorders comprising administering to a patient in need thereof an effective amount of Compound (I) or a pharmaceutically acceptable salt thereof.
Patent CA-2713251-A1 (CA)
Inventor: KAPLAN DAVID L
IPC: A61K6/838
Filed: 2009-02-06
Abstract: Described herein are methods and compositions comprising a mixture of silk polymer and hydroxyapatite. The methods described herein can be used to prepare a mixture of silk polymer and hydroxyapatite and further provide mixtures that can be molded into a desired shape. Also encompassed herein are compositions comprising a mixture of silk polymer and hydroxyapatite having a desired shape, which can further be implanted, for example, to facilitate bone healing or tooth structure or support. Such compositions can also include agents, such as therapeutic agents, or cells.
Patent CA-2718334-A1 (CA)
Inventor: KULKARNI CHIDAMBER R
IPC: G06F12/08
Filed: 2009-03-16
Abstract: A configurable transactional memory (102) synchronizes transactions from clients (104-110). The configurable transactional memory (102) includes a memory buffer (120) and a transactional buffer (128). The memory buffer (120) includes allocation control (124) and storage (126), and the allocation control (124) is configurable to selectively allocate the storage between a transactional buffer (128) and a data buffer (130) for the data words. The transactional buffer (128) stores states (132-134) indicating each combination of a data word and a client for which the data word is referenced by a write access in the transaction in progress from the client. The transactional arbiter (122) generates the completion status for the transaction in progress from each client. The completion status is either committed for no collision or aborted for a collision. A  collision is an access that references a data word of the transaction from the client following a write access that references the data word of another transaction in progress from another client.
Patent CA-2718639-A1 (CA)
Title: Methylphenidate extended release therapeutic drug delivery system
Inventor: PATHAK VINAYAK
IPC: A61K31/4458
Filed: 2009-03-26
Abstract: The present invention relates to an extended release therapeutic drug delivery system comprising a controlled release core matrix composition comprising an active pharmaceutical ingredient such as a central nervous system stimulant (e.g., methylphenidate) and a release controlling agent (i.e., HPMC -K4M, HPMC-K I00M CR or HPMC-K 15 M CR) as well as a controlled release coating layer composition covering the core matrix composition, which comprises controlled release polymers such as Eudragit RL 30D. The extended release therapeutic drug delivery system is for use once or twice daily administration. The present invention also relates to processes for manufacturing such an extended release therapeutic drug delivery system.
Patent CA-2719176-A1 (CA)
Inventor: VILLHAUER EDWIN BERNARD
IPC: A61K31/506
Filed: 2001-06-11
Abstract: The present invention relates to certain N-(substituted glycyl)-2-cyanopyrrolidines of formula I     (see formula I) wherein Y is as defined herein, in free form or in acid addition salt form.  Compounds of formula I inhibit DPP-IV (dipeptidyl-peptidase-IV) activity. They are therefore indicated for use as pharmaceuticals in inhibiting DPP-IV and in the treatment of conditions mediated by DPP-IV, such as non-insulin-dependent diabetes mellitus, arthritis, obesity, osteoporosis and further conditions of impaired glucose tolerance.
Patent CA-2719759-A1 (CA)
Inventor: KING MARK J
IPC: A01G31/02
Filed: 2009-03-13
Abstract: A method and apparatus for growing plants (P) hydroponically includes a plant substrate material (52, 54, 56) comprising activated carbon and/or carbonized fibers with or without additional, non-carbonated, non-activated cellulosic fibers.  The activated carbon and/or carbonized fibers with or without the additional, non-carbonated, non-activated cellulosic fibers are usable in bulk or manufactured into slabs (56) or other configurations by any of a variety of non-woven, woven, molding, or other techniques. The activated carbon and/or carbonized fibers are made from cellulosic or synthetic carbon fibers, for example, bamboo fibers.
Patent CA-2721823-A1 (CA)
Inventor: SIEMONS ROLAND
IPC: B01J8/26
Filed: 2009-04-21
Abstract: The present invention relates to a method of converting a raw material stream into a product stream by passing said raw material stream through a bed of fluidized solid particles and allowing heat exchange to occur between the bed of fluidized solid particles and the raw material stream, said method being characterized in that it alternately employs a production mode and a restoration mode to control the temperature of the bed of fluidized solid particles: -said production mode comprising passing the raw material stream through the bed of fluidized solid particles and allowing the temperature of the fluidized solid particles in the bed to decrease or to increase as a result of the production energy associated with the conversion of the raw materials stream into the product stream; and -said restoration mode comprising restoring the temperature of the bed of fluidized solid particles by passing a restoration stream through the bed of fluidized solid particles to decrease the temperature of the fluidized solid particles in case the temperature of the fluidized solid particles has increased during the production mode or to increase the temperature of the fluidized solid particles in case the temperature of the fluidized solid particles has decreased during the production mode, and that -the fluidized solid particles are kept in the same reactor. The present method enables continuous operation of the fluidized bed reactor without the need of recirculating externally heated or cooled solid bed particles and/or for special heat exchange equipment placed inside or enclosing the fluidized bed reactor.
Patent CA-2722823-A1 (CA)
Inventor: LEHNERT THOMAS
IPC: E21C35/193
Filed: 2010-11-29
Abstract: The invention relates to a bit holder having an insertion projection and having a holding projection, the holding projection comprising a bit receptacle, and the holding projection protruding at least locally from or beyond the insertion projection in the tool feed direction. A bit holder of this kind is designed in service-life-optimized fashion by the fact that the holding projection comprises a supporting segment having a rigid, shaped--on supporting surface that is arranged at least locally in front of the insertion projection in the feed direction.   The invention further relates to a base part for receiving an aforementioned bit holder.
Patent CA-2723296-A1 (CA)
Inventor: SRINIVASAN BALAJI S
IPC: G16B40/00
Filed: 2009-05-18
Abstract: Provided herein are methods, systems, and devices for genetic screening. The genetic screening of two or more individuals can be utilized to predict the phenotype of a child from the group of individuals. Also disclosed is prediction of a phenotype of a child from a subset of biological relatives, such as a potential mother and father, before conception. In many instances, the methods, systems and devices herein are utilized to predict the probability of a child developing a rare genetic disease.
Patent CA-2723301-A1 (CA)
Inventor: RAGHAVAN PRABHU
IPC: G06F19/00
Filed: 2009-05-20
Abstract: A wireless medical room control arrangement includes a wireless controller having a wireless router. A room identifier and a device identifier are stored in the controller. A communication interface sends commands to and receives commands from the wireless controller. In response to commands from the interface, the wireless controller sends wireless control signals to operate medical devices in the room. A room monitor adjacent a doorway provides room identifiers to medical devices and wireless controllers entering the room and provides dummy identifiers to medical devices and controllers exiting the room. The room monitors may connect to a global network processor that determines the location of the medical devices in a medical facility.
Patent CA-2723370-A1 (CA)
Inventor: HANNAH JAMES NOLAN
IPC: F03G7/10
Filed: 2009-05-04
Abstract: A generator is disclosed. The generator comprising at least one layer, the at least one layer defining a cavity and at least one aperture, at least a portion of the at least one layer including a reflective medium, or coatings, the cavity configured to hold a fluid, a fluid inlet coupled to the at least one layer, the fluid inlet in fluid communication with the cavity, and a fluid outlet coupled to the at least one layer, the fluid outlet in fluid communication with the cavity, the fluid configured to absorb radiation, the fluid outlet configured to release the fluid to perform work.
Patent CA-2725595-A1 (CA)
Inventor: CUNNINGHAM NICOLAS
IPC: C09D163/00
Filed: 2009-05-28
Abstract: Coating composition includes curable epoxy resin in solid form, curing agent for the epoxy resin, and filler Fur-ther, there is a polyolefin containing component having a compatibilizer polymer that is a modified polyolefin, a mixture of a polyolefin or olefin copolymer with a functionalized rubber, or both The modified polyolefin and functionalized rubber contain groups reactive with either the epoxy resin or the epoxy curing agent A  polyolefin-based portion that amounts to at least 50% by weight of the polyolefin containing component, and an epoxy-based portion that amounts to at least 50% by weight of the curable epoxy resin have viscosities such that the difference between the viscosity of the polyolefin-based portion and the viscosity of the epoxy-based portion, expressed as a percentage based on the lower of the two viscosities, is less than 40% These viscosities are measured by ASTM D4440 at the Vicat softening points, as measured by ASTM D
Patent CA-2726258-A1 (CA)
Title: Use of a combination of delta-9-tetrahydrocannbinol and cannabidiol in the treatment of brain cancer
Inventor: VELASCO DIEZ GUILLERMO
IPC: A61P35/00
Filed: 2009-06-04
Abstract: The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM).
Patent CA-2726338-A1 (CA)
Inventor: AKSAKAL ORHAN SEYFI
IPC: A61B17/04
Filed: 2009-06-05
Abstract: The invention relates to a remote control mechanism for atraumatic surgical needle where there should be a distance between the hand and the place to be sutured thus, allowing the needle to pass through the tissue (flesh), to be captured and to be released with a single stitch movement and which is also adaptable to the needles of different sizes used for surgical suturing,.
Patent CA-2726540-A1 (CA)
Inventor: BAKER ROBERT G
IPC: G06V10/147
Filed: 2009-05-27
Abstract: An imaging system for producing stereoscopic panoramic images using multiple coplanar pairs of image capture devices with overlapping fields of view held in a rigid structural frame for long term calibration maintenance. Pixels are dynamically adjusted within the imaging system for position, color, brightness, aspect ratio, lens imperfections, imaging chip variations and any other imaging system shortcomings that are identified during calibration processes Correction of pixel information is implemented in various combinations of hardware and software Corrected image data is then available for storage or display or for separate data processing actions such as object distance or volume calculations
Patent CA-2728030-A1 (CA)
Inventor: WASSVIK OLA
IPC: G06F3/042
Filed: 2009-06-22
Abstract: An apparatus is controlled to detect locations of a plurality of objects on a touch surface of a panel (1). An input scanner arrangement introduces at least three beams (B1- B6) of radiation into the panel (1) for propagation by internal reflection, and sweeps the beams (B1-B6) inside the panel across a sensing area, preferably in at least two different principal directions (R1, R2). At least one radiation detector is arranged to receive the beams (B1-B6) from the input scanner arrangement while they are swept across the sensing area. A data processor is connected to the radiation detector(s) and operated to identify the locations based on an attenuation of the beams (B1-B6) caused by the objects touching the touch surface within the sensing area, the attenuation being identifiable from an output signal of the radiation detector(s). Each output signal may be further processed to generate a transmission signal, by dividing the output signal by a background signal which represents the output signal without any object on the touch surface.
Patent CA-2729546-A1 (CA)
Inventor: MARSILJE THOMAS H III
IPC: C07D403/12
Filed: 2009-06-24
Abstract: The invention" provides novel pyrimidine derivatives of formula (I) and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of insulin-like growth factor (IGF-IR) or analplastic lymphoma kinase (ALK).
Patent CA-2730060-A1 (CA)
Title: Exine shells
Inventor: ATKIN STEPHEN
IPC: A23L27/00
Filed: 2009-07-09
Abstract: A whitened exine shell having a degree of whiteness (L*) of greater than 65 measured under D 65 illumination.  The shell can be used as a delivery vehicle for an active substance, or as an antioxidant It can be used in a method of surgery, therapy or diagnosis The invention provides a formulation containing the whitened exine shell together with an active substance, and a method for preparing the shell by isolating an exine shell from a naturally occurring spore under treatment conditions which do not include aceto lysis, and treating the isolated shell or a precursor thereof with a bleaching composition
Patent CA-2730203-A1 (CA)
Inventor: BAAS FRANK
IPC: A61K31/7088
Filed: 2009-07-10
Abstract: La présente invention concerne des antagonistes destinés à inhiber ou bloquer lexpression dun complément de mammifère, par exemple le composant 6 du complément (C6). Linvention a une vaste gamme dutilisations, y compris lutilisation dans la préparation dun médicament destiné à améliorer la régénération nerveuse après une lésion nerveuse aiguë ou chronique chez un mammifère. Dautres applications comprennent lutilisation dans le traitement de la sclérose en plaques seul ou en combinaison avec un autre médicament.
Patent CA-2730982-A1 (CA)
Inventor: ROTH WAYNE D
IPC: G06F17/00
Filed: 2009-07-17
Abstract: Methods and systems are provided which include configurations for the reassigning unit locations of a classification matrix at which two or more classification regions overlap as non-classification regions. In addition, methods and systems are provided which include configurations for mathematically creating classification regions which may be characterized by values which more accurately correspond to measured values of particles. Other embodiments of methods and systems include configurations for acquiring data corresponding to measurable parameters of a particle and identifying a location within a classification matrix to which at least some of the data corresponds. Such methods and systems further include configurations for translating either the data corresponding to the identified unit location or a target space located at known locations within the classification matrix a preset number of predetermined coordinate paths until a conclusion that the particle may be classified to particular particle category or a reject class is attained.
Patent CA-2731398-A1 (CA)
Title: Improved organ protection, preservation and recovery
Inventor: DOBSON GEOFFREY
IPC: A01N1/02
Filed: 2008-07-25
Abstract: This application describes compositions, methods of treatment, and methods of manufacturing a medicament for reducing injury or damage to cells, tissues or organs during ischemia, reperfusion, or following ischemia or trauma. The methods for reducing damage to a cell, tissue or organ comprise administering an effective amount of a composition including (i) a potassium channel opener or agonist and/or adenosine receptor agonist; and (ii) an antiarrhythmic agent. The methods may further include postconditioning the cell, tissue or organ.
Patent CA-2732293-A1 (CA)
Inventor: PETERSON DAVID K L
IPC: A61N1/05
Filed: 2009-07-23
Abstract: A method and neurostimulation system for providing therapy to a patient is provided. A plurality of electrodes is placed adjacent to tissue of the patient. The electrodes include first and second electrodes, with the first electrode having a first tissue contacting surface area and the second electrode having a second tissue contact surface area greater than the first tissue contacting surface area. An-odic electrical current is simultaneously sourced from one of the first and second electrodes to the tissue and while cathodic electrical current is sunk from the tissue to another of the first and second electrodes to provide the therapy to the patient.
Patent CA-2734259-A1 (CA)
Inventor: GILCHRIST JAMES WILSON
IPC: B60K15/077
Filed: 2009-08-24
Abstract: A fuel monitoring device for a vehicle having one or more fuel tank sensors, the fuel monitoring device comprising a control module in communication with the or each fuel tank sensor, wherein the control module is operable to receive data from the or each fuel tank sensor and operable to output fuel level related data toa mobile communications system transmitter for transmission to an end user. The fuel monitoring device may be installed covertly within a vehicle and communicate with the vehicle's fuel tank sensor and, optionally, further sensors. The fuel monitoring device facilitates the transmission of information to an end user allowing the end user to identify occurrences of fuel theft from a remote location and/or the fuel monitoring device is operable to generate an alarm condition in or in the proximity of the vehicle. Data may additionally be audited to identify opportunities to improve operating efficiency of a vehicle, or a fleet of vehicles, or to provide early warning of possible vehicle faults and/or to identify fuel theft.
Patent CA-2737047-A1 (CA)
Inventor: EDWARDS ROBERT
IPC: C07D293/12
Filed: 2008-09-15
Abstract: Methods for overcoming multiple herbicide resistance (MHR) in plants using inhibitors of GST suppression of Formula (I), novel chemical inhibitors of Formula (Ia), compositions comprising compounds of Formula (I), and uses and methods relating thereto.
Patent CA-2737736-A1 (CA)
Inventor: MARKS BRADLEY MICHAEL
IPC: H04L12/16
Filed: 2011-04-19
Abstract: The present disclosure described herein relates to a system and method for distributing messages to electronic devices. The method comprises: identifying a first device that is in communication with a second device; identifying a media that matches at least one attribute associated with at least one of the first and second devices; transmitting the media to the first device; and upon receipt of a notification of approval of the media, transmitting the media to the second device.
Patent CA-2738268-A1 (CA)
Inventor: GAYRARD JEAN-DIDIER
IPC: G01S13/74
Filed: 2011-04-28
Abstract: The invention relates to a distance measurement system (100) for locating a geostationary satellite (SA) equipped with a transponder (22), which comprises: - a central station (10) emitting a distance measurement signal (11), - at least one measurement station (13) receiving the emitted signal, including means for measuring the time of arrival of the emitted signal, and transmitted via the transponder (22) of the satellite, - the central and measurement stations, of known positions, including synchronization means with a common time base (18).  The transponder (22) is that of a satellite telecommunications system (200), and has a bandwidth B; the central station includes means for emitting a specific distance measurement signal (11), distinct from the telecommunications signals transmitted via the transponder, with periodic events and with spread spectrum, the bandwidth of which is included in B.
Patent CA-2742784-A1 (CA)
Title: Oximeter device
Inventor: DONARS DAVE
IPC: A61B5/00
Filed: 2009-11-06
Abstract: An oximeter has a housing configured to have a cavity defining portion that is adapted to be fitted with covers of various dimensions to effect receptacles of different dimensions for accommodating differently sized sensor of sensor assemblies that are matable to the oximeter for sensing physical attributes of a patient. Each of the covers, once fully fitted to the housing, is fixedly latched thereto unless a force that overcomes the latching is applied to remove the cover. The effected receptacle is adapted to biasedly retain a corresponding sensor placed therein. The holstered sensor therefore would not accidentally fall out or be removed from the receptacle, until the user deliberately applies a force to remove the sensor from the receptacle.
Patent CA-2742816-A1 (CA)
Inventor: GIESSELBACH MONIKA
IPC: C08K3/34
Filed: 2009-11-13
Abstract: Quite unexpectedly, by suitably modifying the crystal structure of hydrogarnets of the general formula M II3Mr I-II2(OH)12 (where M II denotes divalent metal ions, especially alkaline earth metal ions, of Group IIA of the periodic table and M III  denotes trivalent metal ions of Group IIIA of the periodic table, especially aluminum) with suitable amounts of incorporated silicate and/or phosphate, flame retardants having both a higher flame retardant efficiency than such traditional mineral flame retardants as ATH and MDH, and a higher thermal stability than ATH can be produced. It has also been found that synthetic hydrogarnets of the general formula M II3Mr III2(OH)12 (where M II and M III are as defined above) having cubic crystal shapes can be produced, and these synthetic hydrogarnets also show high flame retardant efficiency.